Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Rheumatology
•
Crystal Arthritis
Is there any expanded diagnostic workup that you pursue for a young female patient with gout?
Does a strong family history of gout change your approach?
Related Questions
Do you prefer allopurinol or febuxostat for patients with chronic kidney disease who are receiving treatment for asymptomatic hyperuricemia?
When would you recommend uric acid-lowering therapy for a patient with asymptomatic hyperuricemia without comorbidities but with family history of gout?
Can Milwaukee shoulder present with a large subacromial bursitis, or does it predominantly cause joint effusion/destruction?
Do you still consider the use of pegloticase in someone with substantial tophaceous burden despite optimal uric acid levels?
Why are gout flares common in hospitalized patients undergoing diuresis but not commonly observed in cancer patients with hyperuricemia resulting from tumor lysis syndrome?
Do you prefer using losartan in your patients with hypertension and gout due to its uricosuric effects?
Do you delay pegloticase in a patient with an active gout flare?
If a patient who has tolerated allopurinol for a prolonged period of time is subsequently found to be positive for the HLA-B*58:01 gene, how would you manage urate-lowering therapy thereafter?
How do you approach using DMARDs for patients with CPP arthritis who have frequent flares?
Do you routinely recommend barbotage for calcific tendinopathy of the shoulder?